MorphoSys
Martinsried, Germany
Biotechnology
CEO: Simon Moroney, 49
MorphoSys is trying to reproduce the human immune response in a test tube. The company, which was founded in 1992 and went public on the Frankfurt stock exchange in 1999, boasts a library of more than 10 billion human antibodies that can be optimized to target specific diseases. It has several drugs in phase-one clinical trials, one to combat Alzheimer's disease, two aimed at cancer, and another for arthritis.
Business Tools
A-Z Index
List & Rankings
Blogs
- Apple
- Asia
- Autos
- Branding
- Economy
- Investing
- Management Trends
- Real Estate
- Small Business
- Social Media
- Technology
